Regulation of tubulin expression by micro-rnas. implications for drug resistance.

Methods in Cell Biology

Volumn 115, Issue , 2013, Pages 63-74

  Lobert, Sharon ^a   Graichen, Mary E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Micro RNA; Microtubules; MiR 100; MiR 200c; Tubulin; Tubulin isotypes

Indexed keywords

ISOPROTEIN; MICRORNA; MIRN100 MICRORNA, HUMAN; MIRN200 MICRORNA, HUMAN; PACLITAXEL; TUBULIN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; CELL STRAIN MCF 7; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICRO-RNA; MICROTUBULE; MIR-100; MIR-200C; SIGNAL TRANSDUCTION; SPINDLE APPARATUS; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; Β-TUBULIN ISOTYPES;

MICRO-RNA; MICROTUBULES; MIR-100; MIR-200C; TUBULIN; Β-TUBULIN ISOTYPES;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MCF-7 CELLS; MICRORNAS; MICROTUBULES; PACLITAXEL; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SPINDLE APPARATUS; TUBULIN;

EID: 84882705204     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407757-7.00005-0     Document Type: Chapter

References (24)

1. Anonymous, American Cancer Society (2012). Chemotherapy for Breast Cancer. , retrieved 4/21/2013. http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-treating-chemotherapy.
2. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Brown S. RNA sequencing with NGS. Next-generation DNA sequencing informatics 2013, 171-186. Cold Spring Harbor Laboratory Press, New York. S.M. Brown, J. Goecks, J. Taylor (Eds.).
4. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports 2008, 9(6):582-589.
5. Cabral F. Mechanisms of resistance to drugs that interfere with microtubule assembly. The role of microtubules in cell biology, neurobiology and oncology 2008, 337-356. Humana Press, New York, NY. T. Fojo (Ed.).
6. Cittelly D.M., Dimitrova O., Howe E.N., Cochrane D.R., Jean A., Spoelstra N.S., et al. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Molecular Cancer Therapeutics 2012, 11(12):2556-2565.
7. Cochrane D.R., Spoelstra N.S., Howe E.N., Nordeen S.K., Richer J.K. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Molecular Cancer Therapeutics 2009, 8(5):1055-1066.
8. De Donato M., Mariani M., Petrella L., Martinelli E., Zannoni G.F., Vellone V., et al. Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. Journal of Cellular Physiology 2011, 227:1034-1041.
9. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nature Reviews. Cancer 2006, 6:259-269.
10. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
11. Heneghan H.M., Miller N., Kerin M.J. MiRNAs as biomarkers and therapeutic targets in cancer. Current Opinion in Pharmacology 2010, 10:543-550.
12. Jedamzik B., Eckmann C.R. Analysis of RNA-protein complexes by RNA coimmunoprecipitation and RT-PCR analysis from Caenorhabditis elegans 2009, Cold Spring Harb Protoc, 2009(10):pdb.prot5300. 10.1101/pdb.prot5300.
13. Kamath K., Wilson L., Cabral F., Jordan M.A. βIII-Tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. The Journal of Biological Chemistry 2005, 280(13):12902-12907.
14. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166. 10.1186/1471-2164-8-166.
15. Lobert S., Graichen Mary E., Morris K. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells. Biochemistry 2013, In press.
16. Lobert S., Hiser L., Correia J.J. Expression profiling of tubulin isotypes and microtubule interacting proteins using real-time polymerase chain reaction. Methods in cell biology, microtubules, in vitro 2010, Elsevier, Chennai, India. J.J. Correia, L. Wilson (Eds.).
17. Lobert S., Jefferson B., Morris K. Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells. Cytoskeleton 2011, 68:355-362.
18. Nagaraja A.K., Creighton D.J., Yu S., Zhu H., Gunaratne P.H., Reia J.G., et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Molecular Endocrinology 2010, 24(2):447-463.
19. Pachter J.S., Yen T.J., Cleveland D.W. Autoregulation of tubulin expression is achieved through specific degradation of polysomal tubulin mRNAs. Cell 1987, 51:283-292.
20. Redshaw R., Wilkes T., Whale A., Cowen S., Huggett J., Foy C.A. A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability. BioTechniques 2013, 54(3):155-164.
21. Theodorakis N.G., Cleveland D.W. Physical evidence for cotranslational regulation of β-tubulin mRNA degradation. Molecular and Cellular Biology 1992, 12(2):791-799.
22. Yen T.J., Gay D.A., Pachter J.S., Cleveland D.W. Autoregulated changes in stability of polyribosome-bound β-tubulin mRNAs are specified by the first 13 translated nucleotides. Molecular and Cellular Biology 1988, 8(3):1224-1235.
23. Yu Z., Baserga R., Chen L., Wang C., Lisanti M.P., Pestell R.G. MicroRNA, cell cycle and human breast cancer. The American Journal of Pathology 2010, 176(3):1058-1064.
24. Zhang J., Chiodini R., Badr A., Zhang G. The impact of next-generation sequencing on genomics. Journal of Genetics and Genomics 2011, 38(3):95-109.